FAGRON (FAGR.BR) Stock Price, Forecast & Analysis
Europe - Euronext Brussels - EBR:FAGR - BE0003874915 - Common Stock
FAGR.BR Key Statistics, Chart & Performance
The current stock price of FAGR.BR is 21.25 EUR. In the past month the price increased by 0.71%. In the past year, price increased by 27.09%.
FAGR.BR Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| AXNA.DE | AMPLIFON SPA | 25.83 | 3.10B | ||
| AMP.MI | AMPLIFON SPA | 25.72 | 3.09B | ||
| UPR.I | UNIPHAR PLC | 15.77 | 900.71M | ||
| ILM1.DE | MEDIOS AG | 16.25 | 360.71M | ||
| BLC.PA | BASTIDE LE CONFORT MEDICAL | 336.43 | 173.56M | ||
| PRE.MI | PREDICT SPA | 13.92 | 4.65M | ||
| VMED.DE | VIROMED MEDICAL AG | N/A | 72.50M |
Related stock screener links
About FAGR.BR
Company Profile
Fagron NV engages in the development, marketing, and distribution of healthcare products and services. The company is headquartered in Nazareth, Oost-Vlaanderen and currently employs 3,989 full-time employees. The company went IPO on 2007-10-05. The firm specializes in the development, marketing and distribution of healthcare products and services intended for healthcare professionals and institutions. The company operates through the following segments: Essentials, enable pharmacists to compound safe products and optimize their compounding process with equipment and packaging. The portfolio includes pharmaceutical raw materials, compounding equipment, packaging, and supplies; Brands, focuses on developing semi-finished products and pharmaceutical-grade vehicles and reduce the workload for pharmacists; Compounding Services, utilizes raw materials from the Essentials segment and vehicles from the Brands segment for compounding activities, offering both sterile and non-sterile compounded products tailored to patients' specific needs.
Company Info
FAGRON
Venecoweg 20A
Nazareth OOST-VLAANDEREN BE
Employees: 3989
Phone: 3280012880
FAGRON / FAGR.BR FAQ
Can you describe the business of FAGRON?
Fagron NV engages in the development, marketing, and distribution of healthcare products and services. The company is headquartered in Nazareth, Oost-Vlaanderen and currently employs 3,989 full-time employees. The company went IPO on 2007-10-05. The firm specializes in the development, marketing and distribution of healthcare products and services intended for healthcare professionals and institutions. The company operates through the following segments: Essentials, enable pharmacists to compound safe products and optimize their compounding process with equipment and packaging. The portfolio includes pharmaceutical raw materials, compounding equipment, packaging, and supplies; Brands, focuses on developing semi-finished products and pharmaceutical-grade vehicles and reduce the workload for pharmacists; Compounding Services, utilizes raw materials from the Essentials segment and vehicles from the Brands segment for compounding activities, offering both sterile and non-sterile compounded products tailored to patients' specific needs.
What is the current price of FAGR stock?
The current stock price of FAGR.BR is 21.25 EUR. The price decreased by -0.23% in the last trading session.
What is the dividend status of FAGRON?
FAGRON (FAGR.BR) has a dividend yield of 1.18%. The yearly dividend amount is currently 0.29.
How is the ChartMill rating for FAGRON?
FAGR.BR has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
What sector and industry does FAGRON belong to?
FAGRON (FAGR.BR) operates in the Health Care sector and the Health Care Providers & Services industry.
What is FAGRON worth?
FAGRON (FAGR.BR) has a market capitalization of 1.57B EUR. This makes FAGR.BR a Small Cap stock.
FAGR.BR Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to FAGR.BR. When comparing the yearly performance of all stocks, FAGR.BR is one of the better performing stocks in the market, outperforming 84.21% of all stocks.
FAGR.BR Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to FAGR.BR. FAGR.BR has an excellent profitability rating, but there are some minor concerns on its financial health.
FAGR.BR Financial Highlights
Over the last trailing twelve months FAGR.BR reported a non-GAAP Earnings per Share(EPS) of 1.17. The EPS increased by 10% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 9.36% | ||
| ROA | 7.69% | ||
| ROE | 17.17% | ||
| Debt/Equity | 0.78 |
FAGR.BR Forecast & Estimates
13 analysts have analysed FAGR.BR and the average price target is 25.65 EUR. This implies a price increase of 20.69% is expected in the next year compared to the current price of 21.25.
For the next year, analysts expect an EPS growth of 11.14% and a revenue growth 9.01% for FAGR.BR